000			01943 a2200541 4500
005			20250514210915.0
264		0	_c20080320
008			200803s 0 0 eng d
022			_a1440-1746
024	7		_a10.1111/j.1440-1746.2004.03634.x _2doi
040			_aNLM _beng _cNLM
100	1		_aPoo, Jorge Luis
245	0	0	_aTriple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study. _h[electronic resource]
260			_bJournal of gastroenterology and hepatology _cDec 2004
300			_aS79-81 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHepacivirus _xdrug effects
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMexico
650	0	4	_aMiddle Aged
650	0	4	_aPilot Projects
650	0	4	_aPolyethylene Glycols _xtherapeutic use
650	0	4	_aRNA, Viral _xblood
650	0	4	_aRecombinant Proteins
650	0	4	_aRibavirin _xtherapeutic use
650	0	4	_aThymalfasin
650	0	4	_aThymosin _xanalogs & derivatives
650	0	4	_aTime Factors
650	0	4	_aTreatment Failure
650	0	4	_aTreatment Outcome
650	0	4	_aViral Load
650	0	4	_aVirus Replication _xdrug effects
700	1		_aSánchez-Avila, F
700	1		_aKershenobich, D
700	1		_aGarcía-Samper, X
700	1		_aGongora, J
700	1		_aUribe, M
773	0		_tJournal of gastroenterology and hepatology _gvol. 19 Suppl 6 _gp. S79-81
856	4	0	_uhttps://doi.org/10.1111/j.1440-1746.2004.03634.x _zAvailable from publisher's website
999			_c15232891 _d15232891